Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 562 clinical trials
TCM Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis

To Elucidate and Confirm the Theory of XuSunShengJi in the Traditional Chinese Medicine Etiological Pathogenesis of Liver Cirrhosis.

cirrhosis
hbsag
liver disease
hepatitis b surface antigen
  • 8 views
  • 07 Nov, 2020
  • 1 location
SMS-based Lifestyle Intervention for Patients With Liver Cirrhosis With Previous Hepathic Encephalopathy

To investigate whether simple reminders about healthy lifestyle sent via mobile phone text messages can improve the liver cirrhosis severity and prognosis (as assessed by the MELD score

  • 44 views
  • 23 Jan, 2021
  • 1 location
Role of Probiotics in the Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Randomized Placebo Control Trial

% are most susceptible to develop SBP by virtue of having low opsonising activity of ascitic fluid.Patients with liver cirrhosis have significant degrees of imbalance of intestinal

spontaneous bacterial peritonitis
ascites
norfloxacin
cirrhosis
antibiotics
  • 6 views
  • 07 Nov, 2020
  • 1 location
Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes

The clinical study determines the effect of Evogliptin in patients with type 2 diabetes mellitus and chronic hepatitis B to confirm the improvement of hepatic fibrosis.

  • 0 views
  • 25 Jan, 2021
Combination Treatment of NAs and Peg IFN -2b for Hepatitis B Related Compensatory Cirrhosis Patients

compensatory cirrhosis patients will result in higher HBsAg clearance rate and reduce the risk of liver cancer. The investigators plan to enroll about 84 hepatitis B related compensatory cirrhosis patients

  • 0 views
  • 23 Jan, 2021
  • 1 location
Changes in Liver Fibrosis Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy

Hepatitis C virus (HCV) is one of the major globally cause of death and morbidity.Chronic hepatitis C is the leading cause of end-stage liver disease, hepatocellular carcinoma and liver-related death in Egypt.It could be considered a special type of metabolic diseases involving insulin resistance (IR) which accelerates fibrosis and modulation …

ribavirin
daclatasvir
sofosbuvir
liver disease
chronic hepatitis
  • 35 views
  • 25 Jan, 2021
  • 1 location
CAREGIVER: A Trial to Improve the Burden and Distress of Caring for Persons With Decompensated Cirrhosis

The goal of this study is to enroll caretakers of patients with decompensated cirrhosis to determine if written emotional disclosure or resilience training interventions reduce distress and

  • 0 views
  • 24 Jan, 2021
  • 1 location
Assessment of the Correlation Between Serum Levels of Adropin and Degree of Severity of Chronic Liver Disease

patients who have chronic liver disease but does not have established cirrhosis or marked inflammation. The "gold standard" for evaluation and follow up of liver fibrosis and cirrhosis is liver

  • 0 views
  • 27 Jan, 2021
  • 1 location
Levels of Interleukin-6 andTransforming Growth Factor Beta in HCV Patients Sera

might lead to the development of liver cirrhosis or hepato cellular carcinoma.. Egypt has possibly the highest HCV prevalence in the world, 10-20% of the general population

  • 0 views
  • 24 Mar, 2021
  • 1 location
Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma

liver function (Child-pugh A or B). However, the shortcoming of TACE is obvious: hypoxia induced neoangiogenesis after blockage of blood supply of the tumor; repeat TACE deteriorates liver

antineoplastic
cirrhosis
thalidomide
TACE
chemoembolization
  • 1 views
  • 07 Nov, 2020
  • 1 location